Statement of Ownership (sc 13g)
November 01 2018 - 4:03PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Aclaris Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.00001
(Title of Class of Securities)
00461U105
(CUSIP Number)
October 22, 2018
(Date of Event Which Requires Filing of
this Statement)
Check the following box to designate the rule pursuant to which
the Schedule is filed:
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 00461U105
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
D. E. Shaw & Co., L.L.C.
13-3799946
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,049,462
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,049,462
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,049,462
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.0%
|
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
CUSIP No. 00461U105
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
D. E. Shaw & Co., L.P.
13-3695715
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,049,462
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,049,462
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,049,462
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.0%
|
|
12.
|
Type of Reporting Person (See Instructions)
IA, PN
|
CUSIP No. 00461U105
|
|
1.
|
Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities
only)
David E. Shaw
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
[ ]
|
|
|
(b)
|
[ ]
|
|
3.
|
SEC Use Only
|
|
4.
|
Citizenship or Place of Organization
United States
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5.
|
Sole Voting Power
-0-
|
|
|
|
6.
|
Shared Voting Power
2,049,462
|
|
|
|
7.
|
Sole Dispositive Power
-0-
|
|
|
|
8.
|
Shared Dispositive Power
2,049,462
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting
Person
2,049,462
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
5.0%
|
|
12.
|
Type of Reporting Person (See Instructions)
IN
|
Item 1.
|
|
(a)
|
Name of Issuer
|
|
|
Aclaris Therapeutics, Inc.
|
|
(b)
|
Address of Issuer's Principal Executive Offices
|
|
|
640 Lee Road, Suite 200
Wayne, PA 19087
|
|
|
Item 2.
|
|
(a)
|
Name of Person Filing
|
|
|
D. E. Shaw & Co., L.L.C.
D. E. Shaw & Co., L.P.
David E. Shaw
|
|
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
|
The business address for each reporting person is:
1166 Avenue of the Americas, 9
th
Floor
New York, NY 10036
|
|
(c)
|
Citizenship
|
|
|
D. E. Shaw & Co., L.L.C. is a limited
liability company organized under the laws of the state of Delaware.
D. E. Shaw & Co., L.P. is a limited partnership organized under the laws of the state of Delaware.
David E. Shaw is a citizen of the United States of
America.
|
|
(d)
|
Title of Class of Securities
|
|
|
Common Stock, par value $0.00001
|
|
(e)
|
CUSIP Number
|
|
|
00461U105
|
Item 3.
|
If this statement is filed pursuant to Rule 13d-1(b)
or 13d-2(b) or (c), check whether the person filing is a:
|
Not Applicable
|
Item 4.
|
Ownership
|
As of October 22, 2018:
|
(a)
|
Amount beneficially
owned:
|
|
|
|
|
D. E. Shaw & Co., L.L.C.:
|
2,049,462 shares
This is composed of (i) 1,319,847 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 729,146 shares in the name of D. E. Shaw Oculus Portfolios,
L.L.C., and (iii) 469 shares in the name of D. E. Shaw Asymptote Portfolios, L.L.C.
|
|
D. E. Shaw & Co., L.P.:
|
2,049,462 shares
This is composed of (i) 1,319,847 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 729,146 shares in the name of D. E. Shaw Oculus Portfolios,
L.L.C., and (iii) 469 shares in the name of D. E. Shaw Asymptote Portfolios, L.L.C.
|
|
David E. Shaw:
|
2,049,462 shares
This is composed of (i) 1,319,847 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 729,146 shares in the name of D. E. Shaw Oculus Portfolios,
L.L.C., and (iii) 469 shares in the name of D. E. Shaw Asymptote Portfolios, L.L.C.
|
|
D. E. Shaw & Co., L.L.C.:
|
5.0%
|
|
D. E. Shaw & Co., L.P.:
|
5.0%
|
|
David E. Shaw:
|
5.0%
|
|
(c)
|
Number of shares
to which the person has:
|
|
(i)
|
Sole power
to vote or to direct the vote:
|
|
D. E. Shaw & Co., L.L.C.:
|
-0- shares
|
|
D. E. Shaw & Co., L.P.:
|
-0- shares
|
|
David E. Shaw:
|
-0- shares
|
|
(ii)
|
Shared power
to vote or to direct the vote:
|
|
D. E. Shaw
& Co., L.L.C.:
|
2,049,462 shares
|
|
D. E. Shaw & Co., L.P.:
|
2,049,462 shares
|
|
David E. Shaw:
|
2,049,462 shares
|
|
(iii)
|
Sole power
to dispose or to direct the disposition of:
|
|
D. E. Shaw & Co., L.L.C.:
|
-0- shares
|
|
D. E. Shaw & Co., L.P.:
|
-0- shares
|
|
David E. Shaw:
|
-0- shares
|
|
(iv)
|
Shared power
to dispose or to direct the disposition of:
|
|
D. E. Shaw & Co., L.L.C.:
|
2,049,462 shares
|
|
D. E. Shaw & Co., L.P.:
|
2,049,462 shares
|
|
David E. Shaw:
|
2,049,462 shares
|
David E. Shaw does not own any shares directly. By virtue of
David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general
partner of D. E. Shaw & Co., L.P., which in turn is the investment adviser of D. E. Shaw Valence Portfolios,
L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C. and the managing member of D. E. Shaw Adviser, L.L.C., which
in turn is the investment adviser of D. E. Shaw Asymptote Portfolios, L.L.C., and by virtue of David E. Shaw’s
position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw
& Co., L.L.C., which in turn is the manager of D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus
Portfolios, L.L.C. and the managing member of D. E. Shaw Manager, L.L.C., which in turn is the manager of D. E.
Shaw Asymptote Portfolios, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the
shared power to dispose or direct the disposition of, the 2,049,462 shares as described above constituting 5.0% of the outstanding
shares and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares. David E. Shaw disclaims
beneficial ownership of such 2,049,462 shares.
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Not Applicable
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company or Control Person.
|
Not Applicable
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not Applicable
|
Item 9.
|
Notice of Dissolution of Group
|
Not Applicable
|
Item 10.
|
Certification
|
By signing below, each of D. E. Shaw & Co., L.L.C.,
D. E. Shaw & Co., L.P., and David E. Shaw certify that, to the best of such reporting person’s knowledge and
belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of their knowledge
and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Powers of
Attorney, dated March 1, 2017, granted by David E. Shaw in favor of Nathan Thomas, are attached hereto.
Dated: November 1, 2018
|
D. E. Shaw & Co., L.L.C.
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Authorized Signatory
|
|
|
|
|
D. E. Shaw & Co., L.P.
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Chief Compliance Officer
|
|
|
|
|
David E. Shaw
|
|
|
|
By:
|
/s/ Nathan Thomas
|
|
|
Nathan Thomas
|
|
|
Attorney-in-Fact for David E. Shaw
|
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jul 2023 to Jul 2024